COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance
Description
The COVID-19 pandemic saw unprecedented resources and funds driven into research for the development, and subsequent rapid distribution, of vaccines, diagnostics and directly acting antivirals (DAAs). DAAs have undeniably prevented progression and
